GH
ITCI

GAM Holding’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

GAM Holding’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-30,700
Closed -$445K – 900
2017
Q4 		$445K Hold
30,700
– – 0.01% 760
2017
Q3 		$484K Hold
30,700
– – 0.02% 433
2017
Q2 		$381K Hold
30,700
– – 0.01% 859
2017
Q1 		$499K Hold
30,700
– – 0.01% 804
2016
Q4 		$463K Hold
30,700
– – 0.01% 771
2016
Q3 		$468K Sell
30,700
-30,700
-50% -$1.24M 0.01% 727
2016
Q2 		$2.38M Buy
+61,400
New +$2.21M 0.04% 476

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GAM Holding's ITCI Position: Q1 2018 in Review

GAM Holding sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2018, closing a stake of 30,700 shares — an estimated $445K sold.

GAM Holding first reported a position in ITCI in Q2 2016 and held it in 7 quarters. The position peaked at $2.38M in Q2 2016. 131 funds tracked by Wall St. Rank hold ITCI as of Q1 2018.

  • GAM Holding reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2018 after selling out during the quarter.
  • GAM Holding sold 30,700 Intra-Cellular Therapies Inc. shares in Q1 2018, an estimated $445K.
  • GAM Holding first reported a position in Intra-Cellular Therapies Inc. in Q2 2016 and held it in 7 quarters.
  • GAM Holding's Intra-Cellular Therapies Inc. position peaked at $2.38M in Q2 2016.
  • 131 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2018.

Based on GAM Holding's 13F filing for Q1 2018, filed 15 May 2018.